Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 20 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

4 trials in Phase 3/4

Results Transparency

14%

1 of 7 completed trials have results

Key Signals

2 recruiting1 with results

Enrollment Performance

Analytics

Phase 2

5(31.3%)

Phase 4

4(25.0%)

N/A

4(25.0%)

Phase 1

3(18.8%)

16Total

Phase 2(5)

Phase 4(4)

N/A(4)

Phase 1(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (20)

Showing 20 of 20 trials

NCT05770622Phase 4Recruiting

Improving Therapeutic Drug Monitoring and Dosing for Vancomycin in Young Infants With Infections (VANCAPP) (Part 2)

Role: collaborator

NCT07527819Not Yet Recruiting

Evaluating Ovarian Toxicity Outcomes Following Immunotherapy in Patients With Triple-Negative Breast Cancer (TNBC)

Role: collaborator

NCT05382494Phase 4Completed

Intranasal Steroid as Medical Therapy For Sleep-Disordered Breathing in Children

Role: collaborator

NCT06962371Not ApplicableRecruiting

Clinical Feasibility and Evaluation Study of POINT-GUARD Embolic Protection Device During TAVR (GUARDIAN)

Role: collaborator

NCT05120856Not ApplicableCompleted

AAT-App Outpatient Trial

Role: collaborator

NCT06543433Phase 2Not Yet Recruiting

Skincubator, a Novel Incubator for Skin to Skin Contact Feasibility Study

Role: collaborator

NCT05368194Not ApplicableCompleted

Food Intake and Epigenetic Alteration in the Spermatozoa of Singletons and Twins

Role: collaborator

NCT05400616Not ApplicableUnknown

Nasal Microbiota Transfer Therapy in Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)

Role: collaborator

NCT04113993Phase 4Unknown

Bazedoxifene -Treatment for Women With Schizophrenia

Role: collaborator

NCT05182931Phase 2Unknown

A Prospective, Multi-Centre Trial of TKI Redifferentiation Therapy in Patients With RAIR Thyroid Cancer (I-FIRST Study)

Role: collaborator

NCT03413189Unknown

The Effect of Exercise Dosage on Physical Function, Cognition and Disability Following Critical Illness

Role: collaborator

NCT05626959Phase 2Unknown

Evaluating the Efficacy of NTI164 in Young People With Autism Spectrum Disorder

Role: collaborator

NCT05516407Phase 1Unknown

Safety and Efficacy of Oral Full-Spectrum Medicinal Cannabis Plant Extract in Children With Autism Spectrum Disorder.

Role: collaborator

NCT04044703Phase 4Completed

Improving Dosing of Vancomycin in Young Infants With Infections

Role: collaborator

NCT03087110Phase 1Completed

Stem Cells in Umbilical Blood Infusion for CP

Role: collaborator

NCT03844113Phase 2Unknown

Carnosine for Peripheral Vascular Disease

Role: collaborator

NCT04641013Active Not Recruiting

Age-related Clonal Haematopoiesis in an HIV Evaluation Cohort (ARCHIVE)

Role: collaborator

NCT03793231Unknown

fungalAi for Fungal Surveillance & Antifungal Stewardship

Role: collaborator

NCT03063788Phase 1Completed

Imaging the HIV Reservoir

Role: collaborator

NCT03333278Phase 2Completed

The Vitamin C, Hydrocortisone and Thiamine in Patients With Septic Shock Trial

Role: collaborator

All 20 trials loaded